Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

SHE:000623 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 14, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	24,069	20,653	17,098	17,020	21,034	18,957
Market Cap Growth	55.30%	20.79%	0.46%	-19.09%	10.96%	-1.39%
Enterprise Value	23,380	20,126	16,961	17,193	19,596	17,652
Last Close Price	20.53	16.97	14.05	13.65	16.49	14.51
PE Ratio	10.59	13.31	11.71	9.56	11.81	11.09
PS Ratio	10.35	7.91	4.96	5.93	9.13	8.42
PB Ratio	0.80	0.71	0.62	0.65	0.84	0.81
P/TBV Ratio	0.82	0.72	0.64	0.66	0.86	0.82
P/FCF Ratio	299.51	-	-	111.32	1821.95	116.28
P/OCF Ratio	103.37	347.21	251.22	40.15	64.75	48.56
EV/Sales Ratio	10.06	7.71	4.92	5.99	8.51	7.84
EV/EBITDA Ratio	-	442.54	49.91	52.66	97.79	136.07
EV/EBIT Ratio	-	-	126.08	132.35	3339.39	-
EV/FCF Ratio	290.94	-	-	112.45	1697.40	108.28
Debt / Equity Ratio	0.08	0.08	0.11	0.11	0.10	0.11
Debt / EBITDA Ratio	165.60	31.37	8.23	8.41	12.45	19.13
Debt / FCF Ratio	28.15	-	-	19.56	226.58	15.22
Asset Turnover	0.07	0.08	0.11	0.10	0.08	0.09
Inventory Turnover	1.41	1.77	2.02	1.93	1.95	1.70
Quick Ratio	1.66	1.57	1.08	2.25	3.89	4.01
Current Ratio	2.02	1.96	1.29	2.70	4.35	4.47
Return on Equity (ROE)	7.75%	5.35%	5.37%	7.01%	7.29%	7.36%
Return on Assets (ROA)	-0.39%	-0.31%	0.27%	0.27%	0.01%	-0.15%
Return on Capital (ROIC)	-0.41%	-0.32%	0.28%	0.29%	0.01%	-0.16%
Return on Capital Employed (ROCE)	-	-	0.50%	0.40%	0.00%	-
Earnings Yield	9.54%	7.51%	8.54%	10.46%	8.46%	9.01%
FCF Yield	0.33%	-1.04%	-2.06%	0.90%	0.06%	0.86%
Dividend Yield	2.92%	2.95%	4.27%	2.20%	1.82%	1.38%
Payout Ratio	25.79%	68.33%	27.44%	21.21%	14.36%	14.76%
Buyback Yield / Dilution	3.48%	9.08%	0.46%	-3.36%	1.39%	0.28%
Total Shareholder Return	6.36%	12.03%	4.73%	-1.16%	3.21%	1.66%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.